Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 40 in last 24h · 115,255 total before filter · latest 2h ago
40last 24h
1803last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings851M&A104Regulatory25Product16Analyst25
✕ clear all filtersticker: ABTSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
US Stock Market Today: S&P 500 Futures Dip On Tariff And Energy Cost Worries
Simply Wall St.29d agoneutral
US Stock Market Today: S&P 500 Futures Dip On Tariff And Energy Cost Worries

The Morning Bull - US Market Morning Update Friday, Jul, 17 2026 US stock futures are drifting slightly lower this morning, with key index contracts such as the E-mini S&P 500 and Nasdaq-100 off by around 0.1% to 0.4%, as investors weigh tighter financial conditions against mixed global growth signals. A planned 25% US tariff on some Brazilian imports raises questions about costs for companies tied to global trade and agriculture, while US crude stockpiles and the Strategic Petroleum Reserve...

Netflix Earnings, Consumer Sentiment: What to Watch the Rest of the Week
The Wall Street Journal30d agoneutral
Netflix Earnings, Consumer Sentiment: What to Watch the Rest of the Week

Today Earnings (a.m): UnitedHealth, GE Aerospace, U.S. Bancorp, Citizens Financial, Abbott Laboratories, State Street, Taiwan Semiconductor Manufacturing Earnings (p.m.): Netflix, Intuitive Surgical Economic data: Weekly jobless claims, Philadelphia Fed business-outlook survey, retail sales, pending home sales index, business inventories Fed speakers: Fed Vice Chair Philip Jefferson is expected to speak, as is Dallas Fed President Lorie Logan.

Earnings, Warsh Testimony: What to Watch the Rest of the Week
The Wall Street Journal32d agoneutral
Earnings, Warsh Testimony: What to Watch the Rest of the Week

Today Earnings: Johnson & Johnson, Morgan Stanley, BlackRock, PNC Financial Services, Conagra, Cintas, United Airlines, Bank of New York Mellon, Elevance Health, J.B. Hunt, ASML Economic data: Producer-price index data for June, Empire State manufacturing survey, EIA weekly petroleum status report, Fed beige book.

Abbott Laboratories (ABT) must face a Lawsuit over PediaSure, Statements about Children’s Growth
Insider Monkey49d agobearish
Abbott Laboratories (ABT) must face a Lawsuit over PediaSure, Statements about Children’s Growth

Abbott Laboratories (NYSE:ABT) is among the Best Brain-Computer Interface Stocks. On June 4, Reuters reported a federal judge ‌ruled that Abbott Laboratories (NYSE:ABT) must face a proposed class-action lawsuit alleging it misled consumers by marketing PediaSure Grow & Gain drinks as “clinically proven” to help children grow. US District Judge Paul Engelmayer said labeling featuring a […]

Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy
24/7 Wall St.52d agobullish
Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy

Abbott Laboratories (NYSE:ABT) is a stock with characteristics suited to multi-decade ownership, because its four-segment healthcare engine, 54 consecutive years of dividend increases, and recession-resistant end markets give a retirement-focused portfolio something rare: cash compounding that does not require monitoring. Pillar One: Durability Built Into the Business Model Abbott’s revenue flows from four distinct segments ... Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat

Jim Cramer on Boston Scientific: “This Whole Cohort Is Just Too Hard to Own”
Insider Monkey53d agoneutral
Jim Cramer on Boston Scientific: “This Whole Cohort Is Just Too Hard to Own”

Boston Scientific Corporation (NYSE:BSX) was among the stocks Jim Cramer discussed as he said that the Iran peace negotiations could trigger an oil glut, cool inflation, and pull interest rates down. A caller asked about Cramer’s thoughts on the stock, and he replied: Now, I gotta tell you something, I was shocked at the decline […]

Abbott Laboratories (ABT) Slid Due To Its Nutrition Segment’s Sensitivity to Consumer Spending Momentum
Insider Monkey85d agoneutral
Abbott Laboratories (ABT) Slid Due To Its Nutrition Segment’s Sensitivity to Consumer Spending Momentum

Carillon Tower Advisers, an investment management company, released its first-quarter 2026 investor letter for the “Carillon Eagle Growth & Income Fund”. A copy of the letter is available to download here. The first quarter of 2026 was volatile due to market shifts, including increased geopolitical risk and inflation fears from rising energy prices. The S&P declined […]